← All organizations

Recursion Pharmaceuticals Inc.

For profitWebsite ↗

Also known as: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | Recursion Pharmaceuticals Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 5, 2024

Timeline

2010s

Jun 1, 2013
Recursion Pharmaceuticals Inc.— Founded

2020s

Aug 8, 2024
Exscientia Limited— Acquired

Drugs by trial phase (9 distinct, 10 trials)

Phase 3 (1 own, 0 via acquisition)

rec-2282

Phase 2 (4 own, 2 via acquisition)

Phase 1 (0 own, 2 via acquisition)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Exscientia Limited

Recent trials (7)

NCT06678659Lead sponsorPhase 1/Phase 2Nov 5, 2024
NCT06536465Lead sponsorPhase 2Oct 31, 2024
NCT06005974Lead sponsorPhase 2Oct 31, 2023
NCT05985655Lead sponsorPhase 1/Phase 2Jul 6, 2023
NCT05552755Lead sponsorPhase 2Jan 31, 2023
NCT05130866Lead sponsorPhase 2/Phase 3Dec 1, 2021
NCT05085561Lead sponsorPhase 2Dec 1, 2021

Details

Founded: Salt Lake City, UT, US Jun 1, 2013
Last known activity: Nov 5, 2024